NCT00614016View on ClinicalTrials.gov

A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2008

Study Completion Date

June 30, 2008

Conditions
Healthy
Interventions
DRUG

Sodium ST20

single administration of oral dosage form

Trial Locations (1)

98418

Charles River Clinical Services Northwest, Inc., Tacoma

Sponsors
All Listed Sponsors
lead

HemaQuest Pharmaceuticals Inc.

INDUSTRY